Capital Markets Day 2017
(WorldNews Norway)

Biotec Pharmacon ASA (`Biotec`, OSE: BIOTEC) announces today the company´s strategic update and 2020 ambitions at Biotec´s Capital Markets Day 2017 (CMD). The company is currently building revenues in 4 different markets with a 2020 revenue ambition of NOK 150-200 million where partnerships and value creating activities will be key priorities. - Biotec has over the last few years generated a solid platform for future activities that will create long-term shareholder value. Biotec is focusing on...